You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Medtronic
Mallinckrodt
Harvard Business School
Johnson and Johnson
Baxter
AstraZeneca

Last Updated: September 29, 2020

DrugPatentWatch Database Preview

LIDOCATON Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Which patents cover Lidocaton, and when can generic versions of Lidocaton launch?

Lidocaton is a drug marketed by Pharmaton and is included in three NDAs.

The generic ingredient in LIDOCATON is lidocaine hydrochloride. There are twenty-nine drug master file entries for this compound. Thirty-nine suppliers are listed for this compound. Additional details are available on the lidocaine hydrochloride profile page.

US ANDA Litigation and Generic Entry Outlook for Lidocaton

A generic version of LIDOCATON was approved as lidocaine hydrochloride by WOCKHARDT BIO AG on November 18th, 1982.

  Start Trial

Summary for LIDOCATON
Drug patent expirations by year for LIDOCATON

US Patents and Regulatory Information for LIDOCATON

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pharmaton LIDOCATON epinephrine; lidocaine hydrochloride INJECTABLE;INJECTION 084729-001 Aug 17, 1983 DISCN No No   Start Trial   Start Trial   Start Trial
Pharmaton LIDOCATON epinephrine; lidocaine hydrochloride INJECTABLE;INJECTION 084728-001 Aug 17, 1983 DISCN No No   Start Trial   Start Trial   Start Trial
Pharmaton LIDOCATON lidocaine hydrochloride INJECTABLE;INJECTION 084727-001 Aug 17, 1983 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
AstraZeneca
Dow
McKesson
Harvard Business School
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.